Gerber Kawasaki Wealth & Investment Management Sells 9,952 Shares of Docusign Inc. $DOCU

Key Points

• Gerber Kawasaki Wealth & Investment Management reduced its stake in Docusign Inc. by 25.8%, selling 9,952 shares and bringing its total shares to 28,563, valued at approximately $2.32 million.
• Insider transactions revealed that CEO Allan C. Thygesen sold 40,000 shares of Docusign in July, decreasing his total ownership by 21.74%, while an additional 78,552 shares were sold by other insiders over the last quarter.
• Docusign's stock has received mixed analyst ratings, with four analysts giving a Buy rating and twelve issuing a Hold rating, reflecting a consensus of "Hold" with an average target price of $89.77.

Gerber Kawasaki Wealth & Investment Management reduced its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 25.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,563 shares of the company's stock after selling 9,952 shares during the period. Gerber Kawasaki Wealth & Investment Management's holdings in Docusign were worth $2,325,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its position in shares of Docusign by 23.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 822,314 shares of the company's stock worth $73,975,000 after buying an additional 156,841 shares during the last quarter. MML Investors Services LLC raised its position in shares of Docusign by 38.9% during the 4th quarter. MML Investors Services LLC now owns 16,711 shares of the company's stock worth $1,503,000 after buying an additional 4,677 shares in the last quarter. Integrated Wealth Concepts LLC raised its position in shares of Docusign by 57.2% during the 4th quarter. Integrated Wealth Concepts LLC now owns 7,805 shares of the company's stock worth $702,000 after buying an additional 2,841 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in shares of Docusign during the 4th quarter worth about $2,400,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Docusign by 222.9% during the 4th quarter. The Manufacturers Life Insurance Company now owns 172,753 shares of the company's stock worth $15,537,000 after buying an additional 119,245 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of recent analyst reports. Bank of America dropped their price target on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a research report on Friday, June 6th. Robert W. Baird lowered their price objective on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $67.00 to $80.00 in a research note on Friday, June 13th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Four analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $89.77.

Docusign Stock Up 1.5%

Shares of Docusign stock traded up $1.15 during trading on Monday, hitting $76.66. The stock had a trading volume of 2,272,539 shares, compared to its average volume of 2,322,855. The company has a market capitalization of $15.49 billion, a PE ratio of 14.49, a P/E/G ratio of 28.61 and a beta of 1.02. The stock has a 50 day simple moving average of $75.41 and a 200 day simple moving average of $79.67. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.81 by $0.09. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The business had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. During the same period last year, the company posted $0.82 earnings per share. The firm's quarterly revenue was up 7.6% compared to the same quarter last year. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its Board of Directors has initiated a stock buyback plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Insider Buying and Selling at Docusign

In other Docusign news, CFO Blake Jeffrey Grayson sold 15,143 shares of the business's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total value of $1,132,696.40. Following the sale, the chief financial officer owned 110,723 shares of the company's stock, valued at $8,282,080.40. The trade was a 12.03% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the completion of the sale, the director directly owned 8,805 shares in the company, valued at $654,827.85. This trade represents a 5.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,552 shares of company stock worth $5,983,631. Corporate insiders own 1.01% of the company's stock.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.